Evidence map›Paper›PMID 36726536›Full record

ArticleOpen forum infectious diseases2023

Phenotypic Profile of

Raymond M Moseki, Daniel L Barber, Elsa Du Bruyn, Muki Shey, Helen Van der Plas, Robert J Wilkinson, Graeme Meintjes, Catherine Riou

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Raymond M MosekiWellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-7792-7977
Daniel L BarberT Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Elsa Du BruynWellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.
Muki SheyWellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.
Helen Van der PlasInstitute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Robert J WilkinsonWellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.
Graeme MeintjesWellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.
Catherine RiouWellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZANational Institute of Allergy and Infectious Diseases · US

Funding

HIV-associated Tuberculosis Training Program (HATTP)D43TW010559 · FIC · UNIVERSITY OF CAPE TOWN · PI Graeme Ayton Meintjes · 2017 to 2026
$3.0M
Contribution of the CD153/CD30 axis to Mycobacterium tuberculosis control in humansR21AI148027 · NIAID · UNIVERSITY OF CAPE TOWN · PI RIOU, CATHERINE · 2019 to 2020
$291k
FIC NIH HHS D43 TW010559NIAID NIH HHS R21 AI148027Wellcome Trust 211360/Z/18/Z
6 · The paper itself

Abstract

Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is a frequent complication of cotreatment for TB and human immunodeficiency virus (HIV)-1. We characterized Methods: We examined the role of CD4 T-cell transcription factors in a murine model of mycobacterial IRIS. In humans, we used a longitudinal study design to compare the magnitude of antiretroviral therapy, activation, transcription factor profile, and cytotoxic potential of Mtb-specific CD4 T cells between TB-IRIS ( Results: In the murine model, CD4 T-cell expression of Eomesodermin (Eomes), but not Tbet, was associated with experimentally induced IRIS. In patients, TB-IRIS onset was associated with the expansion of Mtb-specific IFNγ Conclusions: Although the murine model of

Indexed as

HIV-1/TB coinfectionimmune activationparadoxical TB-IRISTbet/EomesTh-1 responses

Identifiers

PMID36726536
PMCPMC9879713
OpenAlexW4306403580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.